149 related articles for article (PubMed ID: 32012197)
1. Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells.
Luo Z; Farnham PJ
PLoS One; 2020; 15(2):e0228590. PubMed ID: 32012197
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.
Bijl JJ; van Oostveen JW; Walboomers JM; Brink AT; Vos W; Ossenkoppele GJ; Meijer CJ
Leukemia; 1998 Nov; 12(11):1724-32. PubMed ID: 9823947
[TBL] [Abstract][Full Text] [Related]
3. The role of HOXC6 in prostate cancer development.
Hamid AR; Hoogland AM; Smit F; Jannink S; van Rijt-van de Westerlo C; Jansen CF; van Leenders GJ; Verhaegh GW; Schalken JA
Prostate; 2015 Dec; 75(16):1868-76. PubMed ID: 26310814
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
McCabe CD; Spyropoulos DD; Martin D; Moreno CS
Cancer Res; 2008 Mar; 68(6):1988-96. PubMed ID: 18339881
[TBL] [Abstract][Full Text] [Related]
5. Loss of HOXC6 expression induces apoptosis in prostate cancer cells.
Ramachandran S; Liu P; Young AN; Yin-Goen Q; Lim SD; Laycock N; Amin MB; Carney JK; Marshall FF; Petros JA; Moreno CS
Oncogene; 2005 Jan; 24(1):188-98. PubMed ID: 15637592
[TBL] [Abstract][Full Text] [Related]
6. [Effect of human cytomegalovirus infection on the expression of hoxc4 and hoxc6 genes in the proliferation of lymphocytic progenitor cells].
Feng JQ; Liu WJ; Chen HY; Guo QL; Chen A; Chen SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):141-5. PubMed ID: 19236766
[TBL] [Abstract][Full Text] [Related]
7. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue.
Bijl J; van Oostveen JW; Kreike M; Rieger E; van der Raaij-Helmer LM; Walboomers JM; Corte G; Boncinelli E; van den Brule AJ; Meijer CJ
Blood; 1996 Mar; 87(5):1737-45. PubMed ID: 8634419
[TBL] [Abstract][Full Text] [Related]
8. Aberrant HOXC expression accompanies the malignant phenotype in human prostate.
Miller GJ; Miller HL; van Bokhoven A; Lambert JR; Werahera PN; Schirripa O; Lucia MS; Nordeen SK
Cancer Res; 2003 Sep; 63(18):5879-88. PubMed ID: 14522913
[TBL] [Abstract][Full Text] [Related]
9. HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas.
Bijl JJ; van Oostveen JW; Walboomers JM; Horstman A; van den Brule AJ; Willemze R; Meijer CJ
Blood; 1997 Nov; 90(10):4116-25. PubMed ID: 9354682
[TBL] [Abstract][Full Text] [Related]
10.
Zhou J; Yang X; Song P; Wang H; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305
[No Abstract] [Full Text] [Related]
11. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
12. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
Elife; 2020 Jun; 9():. PubMed ID: 32553107
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.
Leyten GH; Hessels D; Smit FP; Jannink SA; de Jong H; Melchers WJ; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Schalken JA
Clin Cancer Res; 2015 Jul; 21(13):3061-70. PubMed ID: 25788493
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA
Misawa A; Kondo Y; Takei H; Takizawa T
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514011
[TBL] [Abstract][Full Text] [Related]
16. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
17. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
18. Identification of transcription factor co-regulators that drive prostate cancer progression.
Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ
Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156
[TBL] [Abstract][Full Text] [Related]
19. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
[TBL] [Abstract][Full Text] [Related]
20. HOXC6 promotes cervical cancer progression via regulation of Bcl-2.
Wang Y; Wang C; Liu N; Hou J; Xiao W; Wang H
FASEB J; 2019 Mar; 33(3):3901-3911. PubMed ID: 30509141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
